Search

everythinglearnresearchcommunity

for

Search:↓

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Thyroid-stimulating hormone affects hair follicles but doesn't change hair growth or color.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Telocytes in the scalp may help with skin regeneration and maintenance.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Rat hair follicle stem cells have functional oxytocin receptors, useful for studying neuropsychiatric disorders.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Frequent blood transfusions in beta thalassemia patients can lead to thyroid problems.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

An 11-year-old girl with compulsive hair pulling was successfully treated with therapy and medication.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

The Total Excision Techniques improve hair transplant results by increasing grafts by at least 50% and reducing scarring.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

Tretinoin boosts minoxidil's effect on hair loss by increasing enzyme activity.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

The tumescent technique improves hair micrografting by providing lasting anesthesia, reducing bleeding, and increasing patient comfort.

A woman with a unique syndrome similar to TRPS has a genetic change near the TRPS1 gene, affecting its regulation.

Thrombospondin-1 is crucial for hair follicle regression and reduced blood vessel growth during the catagen phase.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

A woman with hypothyroidism developed an allergy to IV levothyroxine after being resistant to oral forms.

Early treatment of traction alopecia can reverse hair loss; prevention involves avoiding tight hairstyles.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.